Loading insider details...
Beta
Latest Form 4 (Jul 8, 2026): Grant/Award of 175,000 KLRA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 8, 2026 | Kailera Therapeutics, Inc. (KLRA) | Grant/Award | 175,000 | n/a |
| Jun 25, 2026 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 10,000 | n/a |
| May 29, 2026 | COMPASS Pathways plc (CMPS) | Grant/Award | 41,119 | n/a |
| Jun 17, 2025 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 20,000 | n/a |
| May 30, 2024 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 20,000 | n/a |
| Jan 23, 2024 | Cerevel Therapeutics Holdings, Inc. (CERE) | Grant/Award | 59,171 | n/a |
| Jan 4, 2024 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 35,604 | $39.9K |
| Oct 10, 2023 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 20,000 | n/a |
| Jan 5, 2023 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 30,943 | $39.9K |
| Sep 19, 2022 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 15,000 | n/a |